Looking for help?

Find answers to your questions

Theradome Contraindications and Safety Precautions

All laser phototherapy devices have two contraindications, scalp cancer patients and pregnant women.

Light therapy is a relatively new modality and some physicians have not been certified in laser phototherapy. Some do not know the difference between UV and near infrared and so they err on the side of caution. It is a well-documented scientific fact that near infrared lasers do not cause cancer.

Theradome near infrared lasers are safe although have not been tested on people with scalp cancer or on fetuses because it is not ethically or economically viable to do so.

Some individuals may not be ideal candidates for Theradome laser therapy based on their level of hair loss. Advanced Norwood and Savin classifications indicate significant follicle miniaturization and low remaining hair density, which limits the potential for laser therapy to restore meaningful growth.

Hamilton-Norwood Scale

Male Hair Loss Classification

Theradome PRO and EVO are FDA cleared to effectively and safely treat hair loss levels IIa, III, IIIa, III vertex, IV, IVa and V.

Ludwig-Savin Scale

Female Hair Loss Classification
Theradome PRO and EVO are FDA cleared to effectively and safely treat hair loss levels I-1, I-2, I-3, I-4, II-1, II-2 and frontal hair loss.

Theradome is also not intended for women who are pregnant or breastfeeding, or for individuals with a history of scalp cancer or suspicious scalp lesions.

To see if you are a good candidate, we recommend that you take our TheraQuiz.

View Our Products